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Inﬂammatory processes are involved in the pathogenesis of diabetic nephropathy.  The aim of this 
study was to clarify the role of mitogen-activated protein kinase (MAPK) pathways for induction of 
intercellular adhesion molecule-1 (ICAM-1) expression in glomerular endothelial cells under diabetic 
conditions.  We examined the expression of ICAM-1 in the kidneys of experimental diabetic rats.  
Human glomerular endothelial cells (GE cells) were exposed to normal glucose concentration,  high 
glucose concentration (HG),  or high mannitol concentration (HM),  and then the expression of the 
ICAM-1 protein and the phosphorylation of the 3 subfamilies of mitogen-activated protein kinase 
(MAPK) were determined using Western blot analysis.  Next,  to evaluate the involvement of MAPKs 
in HG- or HM-induced ICAM-1 expression,  we preincubated GE cells with the inhibitors for ERK,  p38 
or JNK 1h prior to the application of glucose or mannitol.  Expression of ICAM-1 was increased in the 
glomeruli of diabetic rats.  Both HG and HM induced ICAM-1 expression and phosphorylation of 
ERK1/2,  p38 and JNK in GE cells.  Expression of ICAM-1 was signiﬁcantly attenuated by inhibitors of 
ERK,  p38 and JNK.  We conclude that activation of ERK1/2,  p38 and JNK cascades may be involved 
in ICAM-1 expression in glomerular endothelial cells under diabetic conditions.
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iabetic nephropathy is a major cause of end-
stage renal failure worldwide.  Several mecha-
nisms have been postulated for the development of 
diabetic nephropathy.  Glomerular hyperﬁltration,  
which is noted in the early stage of diabetic nephropa-
thy,  causes glomerular injury in type 1 and type 2 
diabetes [1].  Hyperglycemia induces accumulation of 
advanced glycation end products (AGEs) [2],  accel-
eration of the polyol pathway [3],  activation of pro-
tein kinase C [4],  an increases of oxidative stress 
[5],  and overexpression of transforming growth fac-
tor (TGF)-ß [6].  In addition to these factors,  recent 
studies have shown the critical roles of inﬂammatory 
processes in the development of diabetic nephropathy.
　 Inﬁltration of macrophages into the glomeruli and 
interstitium is one of the characteristic features of 
diabetic nephropathy in addition to mesangial matrix 
expansion and interstitial ﬁbrosis.  Furuta et al.  [7] 
reported that the number of macrophages in the glom-
eruli was signiﬁcantly higher in moderate-stage than 
advanced-stage diabetic glomerulosclerosis.  It has also 
been demonstrated that glomerular and interstitial 
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injury is associated with macrophage inﬁltration in 
both type 1 and type 2 diabetes [8,  9].  These results 
suggest the pathological role of macrophages in the 
development of diabetic nephropathy.
　 Intercellular adhesion molecule-1 (ICAM-1) is one 
of the major molecules that promotes leukocyte 
attachment to the vascular endothelium and their 
transmigration by its binding to ß2-integrins on leuko-
cyte cell surfaces . We have reported in a series of 
studies that ICAM-1 is upregulated and mediates 
macrophage inﬁltration in diabetic kidney tissues 
[10-12].  We have also demonstrated that ICAM-1-
deﬁcient mice are protected from renal injury after 
induction of diabetes [13].  Furthermore,  we have 
recently shown that anti-inﬂammatory agents could 
ameliorate experimental diabetic nephropathy through 
inhibition of ICAM-1 expression and macrophage 
inﬁltration [14-17].  
　 It has been reported that exposure of the vascular 
endothelium to elevated glucose concentrations induces 
expression of ICAM-1 in vitro.  A recent study has 
also shown that short-term (24-h) exposure of human 
umbilical vein endothelial cells (HUVEC) to high glu-
cose concentrations resulted in the enhanced expres-
sion of ICAM-1,  vascular cell adhesion molecule-1 
(VCAM-1) and endothelial-leukocyte adhesion mole-
cule-1 (ELAM-1) [18].  Another study demonstrated 
that high glucose can upregulate ICAM-1 protein and 
mRNA expression in rat mesangial cells,  in part 
through osmotic eﬀects,  and that this upregulation of 
promotes leukocyte adhesion [19].  
　 Mitogen-activated protein kinase (MAPK) cascades 
comprise one of the major signaling systems by which 
cells transduce and integrate diverse intracellular 
signals.  The three subfamilies of MAPKs are the 
extracellular signal-regulated kinases (ERKs),  the p38 
MAPKs,  and the c-Jun NH2-terminal kinases (JNK).  
ERKs are activated primarily in response to prolifer-
ated stimuli,  whereas the other MAPKs are activated 
primarily in response to inﬂammatory and stressful 
stimuli,  including oxidant and osmotic stresses.  
　 It has been well established that high glucose 
induces expression of ICAM-1 in diﬀerent cell types,  
but little is known about the intracellular signaling 
pathways leading to adhesion molecule expression.  In 
this study,  we aimed to clarify the involvement of the 
3 subfamilies of MAPKs in the process of ICAM-1 
expression in glomerular endothelial cells under dia-
betic condition.  We evaluated the role of the MAPKs 
in the expression of ICAM-1 induced by high glucose 
or high mannitol in cultured glomerular endothelial 
cells.  
Materials and Methods
　 Reagents and antibodies. Chemicals and 
reagents including D-glucose and D-mannitol were 
obtained from Sigma Chemical (St.  Louis,  MO,  
USA),  unless otherwise noted.  Cell culture medium 
(EBM-2) and growth supplements were purchased 
from Clonetics (Walkersville,  MD,  USA).  Fetal 
bovine serum (FBS) was obtained from CanSera 
International (ON,  Canada).  Mouse monoclonal anti-
rat ICAM-1 antibody (1A29) was purchased from 
Seikagaku Kogyo (Tokyo,  Japan).  FITC-conjugated 
goat anti-mouse IgG was obtained from Jackson 
Immunoresearch Laboratories (West Grove,  PA,  
USA).  Mouse monoclonal anti-ICAM-1 antibody was 
purchased from BD Biosciences Pharmingen (San 
Diego,  CA,  USA).  Rabbit polyclonal anti-phospho-
p38 antibody,  anti-p38 antibody and anti-GAPDH 
antibody were obtained from Santa Cruz 
Biotechnology (Santa Cruz,  CA,  USA).  Rabbit 
polyclonal phospho-MAP kinase 1/2 (Erk1/2) anti-
body,  anti-MAP kinase 1/2 (Erk1/2) antibody,  
phospho-JNK1 antibody and anti-JNK/SAPK were 
purchased from Upstate Biotechnology (Lake Placid,  
NY,  USA).  Alexa Fluor 488 anti-mouse IgG antibody 
was obtained from Molecular Probes (Eugene,  
OR, USA).  ERK inhibitor II,  p38 inhibitor 
(SB203580) and JNK inhibitor (SP600125) were 
purchased from Calbiochem (Darmstadt,  Germany).  
Horseradish peroxidase (HRP)-linked anti-mouse and 
anti-rabbit IgG antibodies and the HRP Western blot 
detection kit were obtained from GE Healthcare Bio-
sciences (Piscataway,  NJ,  USA).
　 Experimental protocol. Male Sprague-Dawley 
rats aged 5 wk were divided into 2 groups:  
nondiabetic control rats (non-DM,  n=5) and strepto-
zotocin (STZ)-induced diabetic rats (DM,  n=5).  DM 
rats were injected intravenously with STZ (65mg/kg 
body wt) in citrate buﬀer (pH4.5).  Blood glucose lev-
els were determined at 3 and 7 days after STZ injec-
tion,  and only rats with blood glucose concentrations＞ 
300mg/dl were used in the study.  Non-DM rats 
received an injection of citrate buﬀer alone.  Rats of 
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the non-DM and DM groups received normal chow.  All 
rats had free access to standard chow and tap water.  
All procedures were performed according to the 
Guidelines for Animal Experiments at Okayama 
University Medical School,  the Japanese Government 
Animal Protection and Management Law (No.  105),  
and the Japanese Government Notiﬁcation on Feeding 
and Safekeeping of Animals (no.  6).  All rats were 
killed 8 weeks after the induction of diabetes,  and the 
kidneys were harvested.  The tissues were embedded 
in optimal-cutting-temperature compound (Sakura 
Finetechnical,  Tokyo,  Japan) and immediately frozen 
in acetone cooled on dry ice.
　 Immunoﬂuorescence staining for ICAM-1 in 
rat kidney. The expression of ICAM-1 was 
detected by indirect immunoﬂuorescence as described 
previously [20,  21].  Brieﬂy,  fresh-frozen sections 
(4-μm thick) were stained with a mouse monoclonal 
anti-rat ICAM-1 antibody (1A29) for 1 h at room 
temperature,  and then stained with FITC-conjugated 
goat anti-mouse IgG for 30min at room temperature.  
The stained sections were observed by a confocal laser 
ﬂuorescence microscope (LSM-510; Carl Zeiss,  
Jena,  Germany).  The immunoﬂuorescence intensities 
of glomerular ICAM-1 were quantiﬁed as follows:  
color images were obtained as TIF ﬁles by LSM-510.  
The brightness of each image ﬁle was uniformly 
enhanced and analyzed using Lumina Vision software 
(Mitani,  Fukui,  Japan).  Image ﬁles (TIF) were 
inverted and opened in gray-scale mode.  
　 Cell culture. Human glomerular endothelial 
cells (GE cells) were obtained from Applied Cell 
Biology Research Institute (Kirkland,  WA, USA) and 
cultured in EBM-2 complete medium containing 5.5 
mM D-glucose and 10ｵ FBS in a 5ｵ-CO2 incubator 
at 37°C.  Cells from each primary ﬂask (passage 4 to 
8) were detached with trypsin/EDTA,  re-suspended 
in fresh culture medium,  and passaged into gelati-
nized 6-well plates for Western blot analysis or 
12-well plates with gelatinized coverslips for immuno-
ﬂuorescence analysis.  GE cells were grown to subcon-
ﬂuence (80ｵ) and then rendered quiescent in EBM-2 
containing 0.1ｵ FBS.  After 24h,  GE cells were 
exposed to the following experimental conditions: 1) 
5.5mM D-glucose (normal glucose; NG),  2) 30mM 
D-glucose (high glucose; HG),  or 3) 5.5mM D-glucose 
plus 24.5mM D-mannitol (high mannitol,  HM),  for 10,  
30 and 60min and 12 and 24h.  When inhibitors were 
used,  cells were preincubated with 1μM ERK 
inhibitor II or 0.5μM SB203580 or 0.1μM 
SP600125 one hour prior to the application of 
D-glucose or D-mannitol.
　 Immunoﬂuorescence microscopy. Cells on 
coverslips were ﬁxed in 3.7ｵ paraformaldehyde in 
PBS for 20min,  washed three times with PBS,  and 
blocked with 5ｵ bovine serum albumin (BSA) in tris-
buﬀered saline containing 0.1ｵ Tween 20 (TBS-T) 
for 30min.  Incubations with mouse monoclonal anti-
ICAM-1 antibody were performed in blocking solution 
(5ｵ BSA in TBS-T) for 1h at room temperature.  
After three washes with TBS-T,  cells were incubated 
with appropriate secondary antibodies conjugated to 
immunoﬂuorescent dyes in blocking solution for 1h at 
room temperature.  After three washes with PBS,  the 
coverslips were mounted using Pristine Mount 
(Pharma,  Tokyo).  The sections were observed under 
a BIOZERO ﬂuorescent microscope BZ-8000 
(Keyence,  Osaka,  Japan).
　Western blot analysis. Western blot analysis 
was performed as described [20,  21].  Brieﬂy,  after 
washing with PBS,  cells prepared on 6-well plates as 
described in the section of cell culture were lysed 
with 300μl per well of cell lysis buﬀer containing 10 
mM Tris (pH 7.4),  1ｵ Triton X-100,  0.5ｵ Nonidet 
P-40,  150mM NaCl,  1mM EDTA,  0.2mM EGTA,  
0.2mM vanadate,  0.2mM PMSF,  and 0.5ｵ phos-
phatase inhibitor cocktail.  The protein concentration 
of the supernatant was measured with an RC DC 
protein assay kit (Bio-Rad,  Hercules, CA,  USA).  
Total cell lysates were cleared by centrifugation and 
boiled with the same amount of 3×SDS sample buﬀer 
for 5min,  then subjected to 7.5ｵ SDS-
polyacrylamide gel electrophoresis (SDS-PAGE).  
The separated proteins were transferred to PVDF 
membranes by electrotransfer.  The blots were subse-
quently blocked with 5ｵ BSA in TBS-T at room 
temperature for 1h,  and then incubated at 4°C over-
night with the proper primary antibody at the dilutions 
recommended by the supplier.  After washing 3 times 
for 10min with TBS-T,  the membrane was incubated 
with a 1: 1000 dilution of HRP-linked anti-mouse or 
rabbit IgG secondary antibody at room temperature 
for 1h.  The blots were then visualized with the ECL 
Western blot detection system.  If membranes needed 
to be reproved,  they were incubated in reproving buf-
fer containing 62.5mM Tris (pH 6.8),  2ｵ deoxy-
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cholate,  and 100mM mercaptoethanol at 70°C for 
30min.  After four 10-min washes with TBS-T,  mem-
branes were incubated with another primary antibody 
and then visualized again.  The amount of detected 
proteins was analyzed using Image Quant (Molecular 
Dynamics,  Chicago,  IL,  USA) software.
　 Statistical analysis. Results are expressed as 
means±SD of 3 to 6 independent experiments.  
Stimulated samples were compared with controls by 
unpaired Studentʼs t test.  For multiple-group com-
parisons,  one-way analysis of variance (ANOVA) fol-
lowed by the post hoc Fisherʼs test was performed 
using StatView software.  P＜0.05 was considered 
statistically signiﬁcant.  
Results
　 Expression of ICAM-1 in kidneys. HbA1c 
and urinary albumin excretion (UAE) are signiﬁcantly 
higher in diabetic rats compared with nondiabetic rats 
(HbA1c; 13.6ｵ vs 3.6ｵ,  UAE; 2090 μg/day vs 
65.4 μg/day,  p＜0.05).  In diabetic rats,  ICAM-1 
expression was increased in glomeruli compared with 
nondiabetic rats (Fig.  1).
　 Eﬀect of high glucose and high mannitol on 
ICAM-1 expression in GE cells. On immuno-
ﬂuorescence microscopy,  ICAM-1 was seen in a ﬁne 
granular pattern on the surface of GE cells.  Although 
ICAM-1 was expressed at low levels in the basal 
state (NG),  its expression was signiﬁcantly increased 
in HG and HM (Fig.  2).  Western blot analysis also 
revealed that exposure to HG and HM induced 
ICAM-1 protein expression in a time-dependent man-
ner in GE cells (Fig.  3).  Exposure to HG increased 
ICAM-1 protein expression 4.18±0.84-fold after 
12h and 5.83±1.22-fold after 24h compared with that 
at baseline (Fig.  3A).  Similarly,  exposure to HM 
increased ICAM-1 protein 2.39±0. 32-fold after 12h 
and 5.36±1.51-fold after 24h (Fig.  3B).
　 Eﬀect of HG and HM on phosphorylation of 
ERK1/2 in GE cells. To examine whether 
ERK1/2 phosphorylation is mediated by HG and HM 
in GE cells,  the activation of these kinases was 
assayed by Western blot using an antibody speciﬁc for 
the phosphorylated,  active forms of ERK1/2.  Both 
HG and HM stimulated phosphorylation of ERK1/2 in 
GE cells (Fig.  4).  The maximal response was obtained 
within 10min and then declined.
　 Eﬀect of HG and HM on phosphorylation of 
p38 in GE cells. To determine whether p38 
phosphorylation is mediated by HG and HM in GE 
cells,  activation of this kinase was assayed by 
Western blot using an antibody speciﬁc for the phos-
phorylated,  active forms of p38.  Both HG and HM 
stimulated phosphorylation of p38 in GE cells (Fig.  
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A B
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Fig.  1　 Immunoﬂuorescence staining for ICAM-1 in the glomeruli of nondiabetic (A) and diabetic rats (B). 
5).  The maximal response was achieved within 10min 
and then slightly declined.  
　 Eﬀect of HG and HM on phosphorylation of 
JNK1 in GE cells. To examine whether JNK1 
phosphorylation is mediated by HG and HM in GE 
cells,  activation of this kinase was assayed by 
Western blot using an antibody speciﬁc for the phos-
phorylated,  active forms of JNK1.  Both HG and HM 
stimulated phosphorylation of JNK1 in GE cells (Fig.  
6),  and the maximal response was obtained within 10 
min and then declined.
　 Involvement of ERK, p38 and JNK for HG- 
and HM-induced expression of ICAM-1 in GE 
cells. To determine whether ERK,  p38 and JNK 
are involved in HG-induced ICAM-1 expression in GE 
cells,  ERK inhibitor II,  p38 inhibitor (SB203580) 
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A
control (NG)
B C
HG HM
Fig.  2　 Immunoﬂuorescence staining for ICAM-1 in GE cells.  GE cells were incubated with 5.5 mM D-glucose (A),  30mM D-glucose 
(B) and 5.5mM D-glucose plus 24.5mM D-mannitol (C) for 24h.
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Fig.  4　 The eﬀect of HG and HM on phosphorylation of ERK1/2 in GE cells.  A,  GE cells were incubated with 30mM D-glucose for the 
indicated time periods.  The resultant total cell lysates were probed with anti-phospho-ERK1/2 antibody and subsequently reprobed with 
anti-ERK1/2 antibody.  The histogram represents the means±SE of densitometric scans of phospho-ERK1/2 bands from 3 independent 
experiments,  normalized by comparison with total ERK1/2 bands and expressed as ratios of the basal level (0min). *p＜0.05.  B In the 
same way,  total cell lysates prepared from HM-stimulated GE cells were analyzed by immunoblotting.
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Fig.  3　 The increase of ICAM-1 expression in GE cells induced by high glucose and high mannitol.  GE cells were incubated with 30 
mM D-glucose (HG) (A) and 5.5mM D-glucose plus 24.5mM D-mannitol (HM) (B) for 12 and 24h.  Total cell lysates were analyzed by 
immunoblotting with anti-ICAM-1 antibody,  as indicated.  The histogram represents the means±SE of densitometric scans of ICAM-1 
protein bands from 5 independent experiments,  normalized by comparison with GAPDH and expressed as ratios of the basal level (0h).  
*p＜0.05.  
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Fig.  5　 The eﬀect of HG and HM on phosphorylation of p38 in GE cells.  A,  GE cells were incubated with 30mM D-glucose for the 
indicated time periods.  The resultant total cell lysates were probed with anti-phospho-p38 antibody and subsequently reprobed with anti-
p38 antibody.  The histogram represents the means±SE of densitometric scans of phospho-p38 bands from 3 independent experiments,  
normalized by comparison with the total p38 band and expressed as ratios of the basal level (0min).  *p＜0.05.  B,  In the same way,  total 
cell lysates prepared from HM-stimulated GE cells were analyzed by immunoblotting.
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Fig.  6　 The eﬀect of HG and HM on phosphorylation of JNK1 in GE cells.  A,  GE cells were incubated with 30mM D-glucose for the 
indicated time periods.  The resultant total cell lysates were probed with anti-phospho-JNK1 antibody and subsequently reprobed with anti-
JNK antibody.  The histogram represents the means±SE of densitometric scans of phospho-JNK1 bands from 3 independent experiments,  
normalized by comparison with total JNK bands and expressed as ratios of the basal level (0min). *p＜0.05.  B,  In the same way,  total cell 
lysates prepared from HM-stimulated GE cells were analyzed by immunoblotting. 
and JNK inhibitor (SP600125) were used.  As shown 
in Fig.  7A,  pretreatment with these inhibitors for 1h 
prior to exposure to HG for 24h caused an attenua-
tion of ICAM-1 expression.  The relative amount of 
ICAM-1 was as follows: NG,  1.00; HG,  2. 96±
0. 46; HG+ERK inhibitor II,  1.09±0.24; HG+ 
SB203580,  0.76±0.26; HG+SP600125,  1.73±
0.28.  Similarly,  we evaluated the eﬀects of ERK 
inhibitor II,  SB203580,  and SP600125 on 
HM-induced ICAM-1 expression.  As shown in Fig.  
7B,  each treatment inhibited the increase of ICAM-1 
expression,  but ERK inhibitor II showed weak inhibi-
tion compared to the other inhibitors.  The relative 
amount of ICAM-1 was as follows: NG,  1.00; HM,  
3.31±0.62; HM+ERK inhibitor II,  2.02±0.69;  
HM+SB203580,  0.95±0.28; HM+SP600125,  
0.91±0.23.
Discussion
　 In this study,  we showed that exposure to HG and 
HM induced ICAM-1 protein expression in a time-
dependent manner in GE cells.  In addition,  we found 
that both HG and HM stimulated phosphorylation of 
ERK1/2,  p38 and JNK1.  HG-induced ICAM-1 
expression was signiﬁcantly attenuated by ERK 
inhibitor II,  SB203580 (an inhibitor of p38),  and 
SP600125 (an inhibitor of JNK).  HM-induced 
ICAM-1 expression was also attenuated by these 
inhibitors.  These results demonstrate that the activa-
tion of the ERK1/2,  p38 and JNK cascades,  at least 
in part,  is essential for HG- and HM-induced ICAM-1 
expression.  
　 The expression of adhesion molecules including 
ICAM-1 constitutes the basis for leukocyte migration 
into endothelial cells processing endothelial inﬂamma-
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Fig.  7　 Involvement of ERK, p38 and JNK for HG- and HM-induced expression of ICAM-1 in GE cells.  A,  Cells were preincubated with 
ERK inhibitor II, SB203580 and SP600125 for 1h, and then incubated with HG for 24h. Total cell lysates were analyzed by immunoblotting 
with anti-ICAM-1 antibody, as indicated. The histogram represents the means±SE of densitometric scans of ICAM-1 protein bands from 6 
independent experiments,  normalized by comparison with the GAPDH band and expressed as ratios of the basal level.  *p＜0.05.  B,  In 
the same way, total cell lysates prepared from HM-stimulated GE cells were analyzed by immunoblotting.
tion.  In diabetic patients,  the induction of adhesion 
molecules on the surface of endothelial cells is one of 
the ﬁrst steps in HG-mediated endothelial dysfunction.  
Previous studies have suggested several possible 
mechanisms of ICAM-1 induction in diabetic renal 
tissues: 1) ICAM-1 is induced by inﬂammatory cytok-
ines such as tumor necrosis factor-α,  interleukin-1,  
and interferon-γ[22]; 2) Activation of protein kinase 
C (PKC) results in upregulation of ICAM-1 in 
endothelial cells [23]; 3) AGEs enhance the expres-
sion of cell adhesion molecules [24,  25]; 4) Shear 
stress stimulates the induction of ICAM-1[26]; 5) 
Oxidative stress increases ICAM-1 expression in 
glomeruli [27]; and 6) Osmotic agents upregulate 
ICAM-1 expression in rat mesangial cells [19] and in 
HUVEC [28].  In this study,  we also showed that 
increased ICAM-1 expression could be induced by HG 
and high concentrations of another osmotic agent,  
mannitol.  Therefore,  in GE cells,  ICAM-1 expres-
sion can be upregulated by hyperglycemia,  at least in 
part by an osmotic eﬀect.
　 The eﬀect of glucose on the activation of MAPKs 
has been examined in diﬀerent cell types.  Previous 
studies demonstrated that the exposure to glucose 
activated both ERKs and p38,  but JNK was not 
phosphorylated in rat aortic smooth muscle cells [29],  
rat mesangial cells [30] and bovine aortic endothelial 
cells [31].  On the other hand,  one study reported 
that neither ERKs nor p38 activity was increased by 
glucose in bovine pulmonary artery endothelial cells 
[32],  and another study showed that HG was capable 
of inducing JNK but not ERKs and p38 in HUVECs 
[33].  Furthermore,  a recent study demonstrated that 
not HG but glucose-induced cytokines activate MAPKs 
in human retinal endothelial cells [34].  These data 
suggest that results vary in diﬀerent cell types.  In the 
present study,  we showed that ERK1/2,  p38 and 
JNK1 were all phosphorylated by HG in GE cells.  
This results are consistent with recent reports show-
ing activation of MAPKs in human diabetic nephropa-
thy [35-37].  Some of the eﬀects of HG are attrib-
uted to an increase in osmolarity.  Hyperosmolarity-
induced activation of ERKs,  JNK,  and p38 has been 
also observed in diﬀerent cell types,  such as mouse 
inner medullary collecting duct cells [38],  bovine 
aortic endothelial cells [39],  and 3T3-L1 adipocytes 
[40].  It seems to be generally the case that p38 and 
JNK are activated by hyperosmotic stress,  whereas 
the response of ERKs to hyperosmotic stress varies 
with the cell type.  In addition,  diﬀerent osmotic 
agents may induce MAPK activation diﬀerently.  One 
study showed that neither ERKs nor p38 activity was 
increased by mannitol in HUVECs [41].  Another 
study demonstrated that mannitol was able to induce 
activation of ERKs,  but no activation of p38 could be 
observed in GP8 rat brain endothelial cells [42].  Our 
study showed that ERK1/2,  p38 and JNK1 were all 
phosphorylated by HM.  Therefore,  in GE cells,  it 
seems that HM is one of the mediators of the activa-
tion of MAPKs observed in HG.
　 Our major ﬁnding was that all 3 subfamilies of 
MAPKs were involved in ICAM-1 expression induced 
by HG in GE cells.  Several studies have demon-
strated that ICAM-1 expression is induced by proin-
ﬂammatory cytokines such as TNF-α and IL-1β,  
either entirely or partly through MAPK signaling 
pathways [43,  44].  However,  there are few reports 
about the involvement between MAPKs and ICAM-1 
expression induced by high glucose itself.  A recent 
study showed that HG-induced ICAM-1 expression 
was inhibited by selenium in HUVECs,  which is par-
tially mediated through the modulation of the p38 
pathway [45].  Another recent study demonstrated 
that chronic p38 inhibition reduced ICAM-1 and 
VCAM-1 expression in the quadriceps muscle in dia-
betic rats [46].  We evaluated similar results regard-
ing the involvement between p38 and HG-induced 
ICAM-1 expression in GE cells.  On the other hand,  
there have been no previous reports evaluating 
involvement between HG-induced ICAM-1 expression 
and ERKs or JNK.  To our knowledge,  this is the 
ﬁrst report to demonstrate not only p38 but also 
ERK- and JNK-mediated ICAM-1 expression induced 
by HG.  This ﬁnding may support the protective role 
of MAPK inhibition in the reduction of the develop-
ment of diabetic nephropathy via anti-inﬂammatory 
mechanisms.  
　 In conclusion,  our study suggests that ERKs,  p38 
and JNK signaling pathways are involved in the 
expression of ICAM-1 induced by both high glucose 
and high osmolarity in GE cells.  All 3 subtypes of 
MAPKs may be involved in the activation of glomeru-
lar endothelial cells in a diabetic milieu.  
255MAPKs in Diabetic GlomerulusAugust 2011
References
 1. Hiragushi K,  Sugimoto H,  Shikata K,  Yamashita T,  Miyatake N,  
Shikata Y,  Wada J,  Kumagai I,  Fukushima M and Makino H: 
Nitric oxide system is involved in glomerular hyperﬁltration in 
Japanese normo- and micro-albuminuric patients with type 2 diabe-
tes.  Diabetes Res Clin Pract (2001) 53: 149-159.
 2. Yang CW,  Vlassara H,  Peten EP,  He CJ,  Striker GE and Striker 
LJ: Advanced glycation end products up-regulate gene expression 
found in diabetic glomerular disease.  Proc Natl Acad Sci U S A 
(1994) 91: 9436-9440.
 3. Dunlop M: Aldose reductase and the role of the polyol pathway in 
diabetic nephropathy.  Kidney Int Suppl (2000) 77: S3-12.
 4. Koya D,  Jirousek MR,  Lin YW,  Ishii H,  Kuboki K and King GL: 
Characterization of protein kinase C beta isoform activation on the 
gene expression of transforming growth factor-beta,  extracellular 
matrix components,  and prostanoids in the glomeruli of diabetic 
rats.  J Clin Invest (1997) 100: 115-126.
 5. Brownlee M: Biochemistry and molecular cell biology of diabetic 
complications.  Nature (2001) 414: 813-820.
 6. Sharma K and Ziyadeh FN: Hyperglycemia and diabetic kidney 
disease.  The case for transforming growth factor-beta as a key 
mediator.  Diabetes (1995) 44: 1139-1146.
 7. Furuta T,  Saito T,  Ootaka T,  Soma J,  Obara K,  Abe K and 
Yoshinaga K: The role of macrophages in diabetic glomeruloscle-
rosis.  Am J Kidney Dis (1993) 21: 480-485.
 8. Sassy-Prigent C,  Heudes D,  Mandet C,  Belair MF,  Michel O,  
Perdereau B,  Bariety J and Bruneval P: Early glomerular mac-
rophage recruitment in streptozotocin-induced diabetic rats.  
Diabetes (2000) 49: 466-475.
 9. Chow F,  Ozols E,  Nikolic-Paterson DJ,  Atkins RC and Tesch GH:  
Macrophages in mouse type 2 diabetic nephropathy: correlation 
with diabetic state and progressive renal injury.  Kidney Int (2004) 
65: 116-128.
10. Sugimoto H,  Shikata K,  Hirata K,  Akiyama K,  Matsuda M,  
Kushiro M,  Shikata Y,  Miyatake M and Makino H: Increased 
expression of intercellular adhesion molecule-1 (ICAM-1) in dia-
betic rat glomeruli: glomerular hyperﬁltration is a potential mecha-
nism of ICAM-1 upregulation.  Diabetes (1997) 46: 2075-2081.
11. Hirata K,  Shikata K,  Matsuda M,  Akiyama K,  Sugimoto H,  
Kushiro M and Makino H: Increased expression of selectins in kid-
neys of patients with diabetic nephropathy.  Diabetologia (1998) 
41: 185-192.
12. Shikata K,  Makino H: Role of macrophages in the pathogenesis of 
diabetic nephropathy.  Contrib Nephrol (2001) 134: 46-54.
13. Okada S,  Shikata K,  Matsuda M,  Ogawa D,  Usui H,  Kido Y,  
Nagase R,  Wada J,  Shikata Y and Makino H: Intercellular adhe-
sion molecule-1-deﬁcient mice are resistant against renal injury 
after induction of diabetes.  Diabetes (2003) 52: 2586-2593.
14. Usui H,  Shikata K,  Matsuda M,  Okada S,  Ogawa D,  Yamashita T,  
Hida K,  Satoh M,  Wada J and Makino H: HMG-CoA reductase 
inhibitor ameliorates diabetic nephropathy by its pleiotropic eﬀects 
in rats.  Nephrol Dial Transplant (2003) 18: 265-272.
15. Tone A,  Shikata K,  Sasaki M,  Ohga S,  Yozai K,  Nishishita S,  
Usui H,  Nagase R,  Ogawa D,  Okada S,  Shikata Y,  Wada J and 
Makino H: Erythromycin ameliorates renal injury via anti-inﬂamma-
tory eﬀects in experimental diabetic rats.  Diabetologia (2005) 
48: 2402-2411.
16. Yozai K,  Shikata K,  Sasaki M,  Tone A,  Ohga S,  Usui H,  Okada S,  
Wada J,  Nagase R,  Ogawa D,  Shikata Y and Makino H: 
Methotrexate prevents renal injury in experimental diabetic rats via 
anti-inﬂammatory actions.  J Am Soc Nephrol (2005) 16: 3326-
3338.
17. Ohga S,  Shikata K,  Yozai K,  Okada S,  Ogawa D,  Usui H,  Wada 
J and Makino H: Thiazolidinedione ameliorates renal injury in 
experimental diabetic rats through anti-inﬂammatory eﬀects medi-
ated by inhibition of NF-kappaB activation.  Am J Physiol Renal 
Physiol (2007) 292: F1141-1150.
18. Altannavch TS,  Roubalova K,  Kucera P and Andel M: Eﬀect of 
high glucose concentrations on expression of ELAM-1,  VCAM-1 
and ICAM-1 in HUVEC with and without cytokine activation.  
Physiol Res (2004) 53: 77-82.
19. Park CW,  Kim JH,  Lee JH,  Kim YS,  Ahn HJ,  Shin YS,  Kim SY,  
Choi EJ,  Chang YS and Bang BK: High glucose-induced intercel-
lular adhesion molecule-1 (ICAM-1) expression through an osmotic 
eﬀect in rat mesangial cells is PKC-NF-kappa B-dependent.  
Diabetologia (2000) 43: 1544-1553.
20. Shikata Y,  Birukov KG,  Birukova AA,  Verin A and Garcia JG:  
Involvement of site-speciﬁc FAK phosphorylation in sphingosine-1 
phosphate- and thrombin-induced focal adhesion remodeling: role 
of Src and GIT.  Faseb J (2003) 17: 2240-2249.
21. Shikata Y,  Birukov KG and Garcia JG: S1P induces FA remodel-
ing in human pulmonary endothelial cells: role of Rac,  GIT1,  FAK,  
and paxillin.  J Appl Physiol (2003) 94: 1193-1203.
22. Wertheimer SJ,  Myers CL,  Wallace RW and Parks 
TP: Intercellular adhesion molecule-1 gene expression in human 
endothelial cells.  Diﬀerential regulation by tumor necrosis factor-
alpha and phorbol myristate acetate.  J Biol Chem (1992) 
267: 12030-12035.
23. Lane TA,  Lamkin GE and Wancewicz E: Modulation of endothelial 
cell expression of intercellular adhesion molecule 1 by protein 
kinase C activation.  Biochem Biophys Res Commun (1989) 
161: 945-952.
24. Vlassara H,  Fuh H,  Donnelly T and Cybulsky M: Advanced glyca-
tion endproducts promote adhesion molecule (VCAM-1,  ICAM-1) 
expression and atheroma formation in normal rabbits.  Mol Med 
(1995) 1: 447-456.
25. Sengoelge G,  Fodinger M,  Skoupy S,  Ferrara I,  Zangerle C,  
Rogy M,  Höri WH,  Sundev-plassmann G and Menzel J. :  
Endothelial cell adhesion molecule and PMNL response to inﬂam-
matory stimuli and AGE-modiﬁed ﬁbronectin.  Kidney Int (1998) 
54: 1637-1651.
26. Nagel T,  Resnick N,  Atkinson WJ,  Dewey CF Jr and Gimbrone 
MA,  Jr. : Shear stress selectively upregulates intercellular adhe-
sion molecule-1 expression in cultured human vascular endothelial 
cells.  J Clin Invest (1994) 94: 885-891.
27. Lo SK,  Janakidevi K,  Lai L and Malik AB: Hydrogen peroxide-
induced increase in endothelial adhesiveness is dependent on 
ICAM-1 activation.  Am J Physiol (1993) 264: L406-412.
28. Taki H,  Kashiwagi A,  Tanaka Y and Horiike K: Expression of 
intercellular adhesion molecules 1 (ICAM-1) via an osmotic eﬀect 
in human umbilical vein endothelial cells exposed to high glucose 
medium.  Life Sci (1996) 58: 1713-1721.
29. Igarashi M,  Wakasaki H,  Takahara N,  Ishii H,  Jiang ZY,  
Yamauchi T,  Kuboki K,  Meler M,  Rhodes CJ and King GL: 
Glucose or diabetes activates p38 mitogen-activated protein 
kinase via diﬀerent pathways.  J Clin Invest (1999) 103: 185-195.
30. Kang MJ,  Wu X,  Ly H,  Thai K and Scholey JW: Eﬀect of glucose 
on stress-activated protein kinase activity in mesangial cells and 
diabetic glomeruli.  Kidney Int (1999) 55: 2203-2214.
31. Duzgun SA,  Rasque H,  Kito H,  Azuma N,  Li W,  Basson MD,  
Gahtan V,  Dudrick SJ and Sumpio BE: Mitogen-activated protein 
256 Acta Med.  Okayama　Vol.  65,  No.  4Watanabe et al.
phosphorylation in endothelial cells exposed to hyperosmolar con-
ditions.  J Cell Biochem (2000) 76: 567-571.
32. Liu W,  Schoenkerman A and Lowe WL Jr: Activation of members 
of the mitogen-activated protein kinase family by glucose in 
endothelial cells.  Am J Physiol Endocrinol Metab (2000) 
279: E782-790.
33. Ho FM,  Liu SH,  Liau CS,  Huang PJ and Lin-Shiau SY: High glu-
cose-induced apoptosis in human endothelial cells is mediated by 
sequential activations of c-Jun NH (2)-terminal kinase and cas-
pase-3.  Circulation (2000) 101: 2618-2624.
34. Busik JV,  Mohr S and Grant MB: Hyperglycemia-induced reactive 
oxygen species toxicity to endothelial cells is dependent on para-
crine mediators.  Diabetes (2008) 57: 1952-1965.
35. Adhikary L,  Chow F,  Nikolic-Paterson DJ,  Stambe C,  Dowling J,  
Atkins RC and Tesch GH: Abnormal p38 mitogen-activated protein 
kinase signalling in human and experimental diabetic nephropathy.  
Diabetologia (2004) 47: 1210-1222.
36. Sakai N,  Wada T,  Furuichi K,  Iwata Y,  Yoshimoto K,  Kitagawa K,  
Kokubo S,  Kobayashi M,  Hara A,  Yamahana J,  Okumura T,  
Takasawa K,  Takeda S,  Yoshimura M,  Kida H and Yokoyama H: 
Involvement of extracellular signal-regulated kinase and p38 in 
human diabetic nephropathy.  Am J Kidney Dis (2005) 45: 54-65.
37. De Borst MH,  Prakash J,  Melenhorst WB,  van den Heuvel MC,  
Kok RJ,  Navis G and Van Goor H: Glomerular and tubular induc-
tion of the transcription factor c-Jun in human renal disease.  J 
Pathol (2007) 213: 219-228.
38. Berl T,  Siriwardana G,  Ao L,  Butterﬁeld LM and Heasley LE:  
Multiple mitogen-activated protein kinases are regulated by hyper-
osmolality in mouse IMCD cells.  Am J Physiol (1997) 272: F305-
311.
39. Malek AM,  Goss GG,  Jiang L,  Izumo S and Alper SL: Mannitol at 
clinical concentrations activates multiple signaling pathways and 
induces apoptosis in endothelial cells.  Stroke (1998) 29: 2631-
2640.
40. Kayali AG,  Austin DA and Webster NJ: Stimulation of MAPK cas-
cades by insulin and osmotic shock: lack of an involvement of p38 
mitogen-activated protein kinase in glucose transport in 3T3-L1 
adipocytes.  Diabetes (2000) 49: 1783-1793.
41. McGinn S,  Saad S,  Poronnik P and Pollock CA: High glucose-
mediated eﬀects on endothelial cell proliferation occur via p38 
MAP kinase.  Am J Physiol Endocrinol Metab (2003) 285: E708-
717.
42. Farkas A,  Szatmari E,  Orbok A,  Wilhelm I,  Wejksza K,  Nagyoszi P,  
Hutamekalin P,  Bauer H,  Traweger A and Krizbai A: Hyperosmotic 
mannitol induces Src kinase-dependent phosphorylation of beta-
catenin in cerebral endothelial cells.  J Neurosci Res (2005) 
80: 855-861.
43. Kuldo JM,  Westra J,  Asgeirsdottir SA,  Kok RJ,  Oosterhuis K,  
Rots MG,  Schouten JP,  Limburg PC and Molema G: Diﬀerential 
eﬀects of NF-{kappa}B and p38 MAPK inhibitors and combina-
tions thereof on TNF-{α}-and IL-1{β}-induced proinﬂammatory 
status of endothelial cells in vitro.  Am J Physiol Cell Physiol (2005) 
289: C1229-1239.
44. Nizamutdinova IT,  Oh HM,  Min YN,  Park SH,  Lee MJ,  Kim JS,  
Yean MH,  Kang SS,  Kim YS,  Chang KC and Kim HJ: Paeonol 
suppresses intercellular adhesion molecule-1 expression in tumor 
necrosis factor-alpha-stimulated human umbilical vein endothelial 
cells by blocking p38,  ERK and nuclear factor-kappaB signaling 
pathways.  Int Immunopharmacol (2007) 7: 343-350.
45. Zheng HT,  Zhou LN,  Huang CJ,  Hua X,  Jian R,  Su BH and Fang 
F: Selenium inhibits high glucose- and high insulin-induced adhe-
sion molecule expression in vascular endothelial cells.  Arch Med 
Res (2008) 39: 373-379.
46. Riad A,  Unger D,  Du J,  Westermann D,  Mohr Z,  Sobirey M,  
Dorenkamp M,  Schultheiss HP and Tschöpe C: Chronic inhibition 
of p38MAPK improves cardiac and endothelial function in experi-
mental diabetes mellitus.  Eur J Pharmacol (2007) 554: 40-45.
257MAPKs in Diabetic GlomerulusAugust 2011
